Transcranial Magnetic Stimulation Clinical Trials 2024

What are the top hospitals conducting transcranial magnetic stimulation research?

When it comes to innovative treatments for mental health conditions, transcranial magnetic stimulation (TMS) is emerging as a promising therapy. Stanford School of Medicine's Department of Psychiatry and Behavioral Sciences in Stanford leads the way with four active TMS trials. Located in California, this prestigious institution is at the forefront of exploring the potential benefits and applications of this non-invasive technique. Meanwhile, the Medical University of South carolina in Charleston is also making strides with three ongoing TMS trials. This progressive medical center aims to harness the power of magnetic fields to treat various neurological and psychiatric disorders.

Further west, within Palo Alto's VA Palo Alto Health Care System lies another hub for cutting-edge research into TMS. With three active clinical trials, this facility focuses on understanding how magnetic stimulation can aid patients suffering from a range of mental health conditions. On the East Coast, Rutgers University - Newark contributes to expanding our knowledge by conducting two current TMS trials. As part of their commitment to advancements in neuroscience, researchers explore how targeted magnetism could potentially alleviate symptoms associated with psychiatric disorders.

Across the border in Toronto stands an influential institution known as The Centre for Addiction and Mental Health (CAMH). Here researchers are delving into novel ways to utilize transcranial magnetic stimulation through two ongoing clinical trials. CAMH’s expertise extends beyond conventional therapies and pushes boundaries towards finding safe yet effective interventions that can transform lives affected by psychiatric illnesses.

These hospitals represent just a few examples among many institutions worldwide that are dedicated to unraveling the complexities surrounding transcranial magnetic stimulation. By conducting rigorous studies and offering hope through these groundbreaking trials, they bring us closer than ever before to unlocking new avenues for treating mental health disorders using state-of-the-art technology such as TMS

Which are the best cities for transcranial magnetic stimulation clinical trials?

When it comes to transcranial magnetic stimulation (TMS) clinical trials, several cities show promising research and development. Stanford in California leads the way with 8 active trials investigating interventions like Active TBS-DLPFC and right OFC. Toronto in Ontario follows closely behind with 7 ongoing studies focusing on treatments such as Active iTBS and repetitive TMS. Charleston in South carolina also shows potential with 6 active trials exploring techniques like TMS and Dose Step 6 - 60 Active Accelerated iTBS Sessions. These cities offer individuals seeking TMS therapies access to cutting-edge clinical trials that pave the way for advancements in neuromodulation treatment options.

Which are the top treatments for transcranial magnetic stimulation being explored in clinical trials?

In the realm of transcranial magnetic stimulation, clinical trials are focusing on several standout treatments. Here are the top contenders being explored:

• Repetitive Transcranial Magnetic Stimulation (rTMS): A well-established treatment that has shown promise in addressing various neurological and psychiatric conditions.
• Deep Transcranial Magnetic Stimulation (dTMS): This technique allows for targeted stimulation of deeper brain regions, offering potential benefits for a range of neurological disorders.
• Theta Burst Stimulation (TBS): TBS is an emerging approach that delivers shorter bursts of magnetic pulses at higher frequencies, showing potential as a more time-efficient treatment option.

These treatments represent exciting avenues of research and hold significant promise in advancing our understanding and application of transcranial magnetic stimulation.

What are the most recent clinical trials for transcranial magnetic stimulation?

Recent advancements in transcranial magnetic stimulation (TMS) have sparked new possibilities for treating various neurological conditions. Among the latest clinical trials is a Phase 2 study investigating active TMS as a potential therapy. Another trial focuses on healthy control subjects, shedding light on the effects of TMS in individuals without underlying neurological disorders. Additionally, a Phase 2 study explores individualized resting state functional connectivity targeting with real-time TMS to enhance treatment outcomes. Furthermore, researchers are exploring adjunctive eTMS treatment without delay through combined Phase 2 and Phase 3 studies. These ongoing trials offer promising avenues for understanding and harnessing the therapeutic potential of TMS in diverse populations affected by neurological conditions.

What transcranial magnetic stimulation clinical trials were recently completed?

Several recent clinical trials have examined the efficacy and potential benefits of transcranial magnetic stimulation (TMS). These studies involve the use of TMS for various neurologic and psychiatric conditions. Notable completed trials include investigations into TMS as a treatment for major depressive disorder, obsessive-compulsive disorder, and chronic pain management. The findings from these trials provide valuable insights into the effectiveness of TMS in addressing these specific conditions and offer hope for patients seeking alternative therapeutic options.